Endocrinological abnormalities and Takotsubo cardiomyopathy
We read with much excitement in the article “Takotsubo syndrome and pheochromocytoma: an insidious combination” published by Maffé et al. in your esteemed journal...
Maffè S, Dellavesa P, Paffoni P, et al. Takotsubo syndrome and pheochromocytoma: An insidious combination. Monaldi Arch Chest Dis 2021. Online ahead of print. https://doi.org/10.4081/monaldi.2021.1711 DOI: https://doi.org/10.4081/monaldi.2021.1711
De Giorgi A, Fabbian F, Tiseo R, et al. Takotsubo cardiomyopathy and endocrine disorders: a mini-review of case reports. Am J Emerg Med 2014;32:1413-7. DOI: https://doi.org/10.1016/j.ajem.2014.07.030
Gupta S, Goyal P, Idrees S, et al. Association of endocrine conditions with takotsubo cardiomyopathy: A comprehensive review. J Am Heart Assoc 2018;7:e009003. DOI: https://doi.org/10.1161/JAHA.118.009003
Pelliccia F, Pasceri V, Patti G, et al. Long-term prognosis and outcome predictors in takotsubo syndrome: A systematic review and meta-regression study. JACC Heart Fail 2019;7:143-54. DOI: https://doi.org/10.1016/j.jchf.2018.10.009
- Abstract views: 258
- PDF: 109
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.